CMS Provides Additional Clarity Regarding 2024 DMEPOS Reimbursement

Published in Billing, Reimbursement, Audits and Compliance on December 20, 2023

The VGM Government Relations team dives deep into the current state of reimbursement, the CPI-U adjustments, blended rates, and other noteworthy changes coming in 2024.

A Reimbursement Update and Strategic Insights from VGM's SVP of Strategy, Alan Morris

Over the past couple of days, HME providers have been given more clarity regarding the Medicare reimbursement landscape for 2024. For starters, CMS will release the full fee DMEPOS fee schedule for 2024, which you can find here, under file name DME24-A.

In addition to that, CMS has released their document titled “Calendar Year 2024 Update for Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Fee Schedule,” which contains several additional updates regarding DMEPOS reimbursement changes that are happening for 2024, many of which are outlined below. That full document can be found here, and several of the key provisions are outlined below.

CPI-U Increases for 2024

The reimbursement rates contained within the newly released fee schedule include the annual inflation factor (CPI-U), which is discussed in detail in the article linked above. These new rates will be applied to DMEPOS items effective for dates of service Jan. 1, 2024 and after, with an implementation date of Jan. 2, 2024. The applicable CPI-U adjustments vary slightly and are dependent upon both the item provided and the location of the patient to whom it was provided. The breakdown of adjustments is as follows:

  • Competitive bid (CB) items in former CBAs: +2.9% 
  • CB items in non-CBAs: +3% 
  • Non-CB items: +2.6% 
    *calculating the new rates for items in areas with blended rates in place, the CPI-U increase only applies to the fully adjusted portion of the rate, not the unadjusted portion.

Other Noteworthy Changes to Reimbursement

  • Therapeutic Shoes
    • Updates being made to A5503 – A5507, as well as A5512, A5513, A5514.
  • Diabetic Testing Supplies
    • Mail order diabetic testing supplies, billed with the KL modifier, will receive a 2.9% CPI-U increase for 2024.
  • Oxygen Maintenance and Service (MS modifier) – 2.6% increase
  • Labor/Repair/Service Codes (K0739, L4205, L7520) – 3% increase
  • Suppliers may continue to use the KE modifier for wheelchair accessories when applicable
  • New and deleted HCPCS Codes and Fee Schedule Amounts
    • Approximately 70 new codes were created for compression garments and related accessories that will be covered beginning Jan. 1, 2024, for patients diagnosed with lymphedema.

Blended Rates

Despite the additional clarity provided by CMS, the future of the blended rates, namely the 75/25 blended rates for non-rural, non-competitive bid areas, remains undetermined. While those rates are currently set to expire on

Dec. 31, 2023, there are two pieces of legislation, S.1294 and H.R. 5555, containing language which would extend those blended rates for another 12 months, through Dec. 31, 2024. H.R. 5555 initially included language that would introduce a 90/10 blended rate for the 130 CBAs for 2024, but that language was removed from that bill as it passed through committee hearings.

While the newly released fee schedule does not currently include the 75/25 blended rates, there is still a good chance those rates will be extended for 2024. Should that happen, CMS will apply those higher reimbursement rates retroactively to Jan. 1, 2024. It is entirely up to you whether you want to submit claims right away in 2024 and have CMS reprocess them if the fee schedule does change early in the year, or wait to see whether the fee schedule changes, and if it does, wait to submit your claims until the change is implemented.

VGM will be watching this issue closely and will update you as needed with any new developments related to this topic. Please reach out to VGM Government Relations with any questions at 800-642-6065.

From Our Experts

Ronda Vlog: Further Updates on Refill Requirements and Dear Physician Letter thumbnail Ronda Vlog: Further Updates on Refill Requirements and Dear Physician Letter Be sure to watch this update from Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement, where she gives updates on the change to the refill requirement, effective Jan. 1, 2024 and the Dear Physician letter released in February. Ronda Vlog: Register Today for the Upcoming Billing and Reimbursement Roadshows thumbnail Ronda Vlog: Register Today for the Upcoming Billing and Reimbursement Roadshows Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement, gives more information on the upcoming in-person billing and reimbursement roadshows. CMS Announces Temporary Gap Period Coming in 2024 thumbnail CMS Announces Temporary Gap Period Coming in 2024 CMS finally released the notice with details regarding the competitive bidding program (CBP) and a temporary gap period. CMS has done this same process in the past prior to the 2021 CBP round. Reducing Medicare Payments for Urinary Catheters thumbnail Reducing Medicare Payments for Urinary Catheters The Office of Evaluation and Inspection, a component of OIG (Office of Inspector General) and HHS (Health and Human Services), recently released "Reducing Medicare's Payment Rates for Intermittent Urinary Catheters Can Save the Program and Beneficiaries Millions of Dollars Each Year,” a study that was performed on urinary catheters. An Open Discussion About Opportunities in the Diabetic Market, CGM Audits, and Reimbursements thumbnail An Open Discussion About Opportunities in the Diabetic Market, CGM Audits, and Reimbursements In this episode of Industry Matters, we talk with president of The van Halem Group, Wayne van Halem, and sales manager for GEMCO, Joseph Ault, about CGM audits, qualifications for reimbursement and documentation, as well as the opportunities in the diabetic market. Featured Service: The van Halem Group thumbnail Featured Service: The van Halem Group There's been a lot of questions and confusion surrounding telehealth services and how they relate to DMEPOS claims. This article by Wayne van Halem, originally featured in “VGM Playbook: Technology and the Patient Care Continuum Guide to Remote Work,” addresses whether or not telehealth services can be used to qualify a patient for an item of DMEPOS during the PHE. Return of the Audits thumbnail Return of the Audits HME Business recently wrote about the news that CMS planned to resume audits by Aug. 3 and that it took many by surprise. Then CMS said it would resume audits in a phased approach. What are the details and what can providers expect? CMS Audits Resume August 3, 2020 thumbnail CMS Audits Resume August 3, 2020 In this episode, we chat with Wayne van Halem and Kelly Grahovac of The van Halem Group about the CMS audits returning today, August 3, and what DMEPOS providers need to know.